Related Experiment Videos
[Fibrinogen: a "new" cardiovascular risk factor].
1Universitätsklinik für Physikalische Medizin und Rehabilitation, Wien.
Wiener Medizinische Wochenschrift (1946)
|January 1, 1991
Summary
Fibrinogen is a key cardiovascular risk factor, yet its normal levels, synthesis control, and harmful mechanisms remain unclear. Current knowledge aids risk identification and plasma fibrinogen normalization, pending stronger causal evidence.
Area of Science:
- Biochemistry
- Cardiology
- Hematology
Context:
- Fibrinogen is recognized as a significant risk factor for cardiovascular disease.
- Despite its established role, fundamental aspects of fibrinogen biology and its impact on circulation are not fully understood.
Purpose:
- To review the current understanding of fibrinogen as a cardiovascular risk factor.
- To highlight knowledge gaps concerning fibrinogen synthesis, regulation, and pathogenic mechanisms.
- To discuss the practical applications of existing knowledge in risk stratification and therapeutic interventions.
Summary:
- Fibrinogen, a critical protein in blood coagulation, is strongly implicated as a major contributor to cardiovascular risk.
- Significant gaps exist in our knowledge regarding the determinants of normal fibrinogen levels, the biochemical pathways controlling its synthesis, and the precise mechanisms by which it adversely affects the circulatory system.
- Existing knowledge allows for the identification of individuals at elevated cardiovascular risk based on fibrinogen levels and offers strategies for plasma fibrinogen normalization.
Impact:
- Advances understanding of fibrinogen's role in cardiovascular pathology.
- Provides a basis for improved cardiovascular risk assessment and management strategies.
- Identifies key areas for future research into fibrinogen metabolism and its clinical implications.